ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fekete, F.
Right arrow Articles by Flejou, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fekete, F.
Right arrow Articles by Flejou, J. F.

The Annals of Thoracic Surgery, Vol 58, 837-842, Copyright © 1994 by The Society of Thoracic Surgeons

ARTICLES

Associated primary esophageal and lung carcinoma: a study of 39 patients

F Fekete, A Sauvanet, G Kaisserian, B Jauffret, K Zouari, L Berthoux and JF Flejou
Department of Digestive Surgery, Hopital Beaujon, Universite Paris VII, France.

From 1979 to 1992, of 1,294 patients with esophageal squamous cell carcinoma, 39 patients (3.2%) (38 male patients, 1 female patient; mean age, 58 years) had associated primary lung carcinoma. Criteria for the diagnosis of primary lung carcinoma were: (1) non-squamous cell carcinoma tumors, (2) tumors existing before the esophageal squamous cell carcinoma, and (3) solitary squamous cell carcinoma presenting with endobronchial involvement. The two tumors were observed synchronously in 22 patients (56%) and metachronously in 17, with a mean tumor-free interval of 46 months (range, 18 to 77 months). In patients with synchronous disease, 10 underwent nonoperative treatment or a palliative surgical procedure, and 12 (55%) underwent a curative operation. In patients with metachronous disease, a curative operation was performed in all for the first tumor and in 9 (53%) for the second tumor. The overall postoperative mortality rate was 15%. Two patients (10%) died after the curative operation. None of the patients died who underwent curative esophagectomy combined with lobectomy. For the patients with synchronous disease, the 5-year survival rate was 11% in those who underwent a curative operation, and the longest survival in those who received palliative treatment was 18 months. For the patients with metachronous disease, the 5-year survival rates from the date of the diagnosis of the second tumor were 17% for those who had a curative operation and 11% for those who received palliative treatment.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 Jpn J Clin OncolHome page
Y. Tachimori
Cancer Screening in Patients with Cancer
Jpn. J. Clin. Oncol., April 1, 2002; 32(4): 118 - 119.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. Kuhn, S. Pasch, W. Wojciechowski, and P. Macchiarini
COMBINED SLEEVE LOBECTOMY AND IVOR LEWIS ESOPHAGECTOMY FOR SYNCHRONOUS PRIMARY CARCINOMA OF THE LUNG AND BARRETT ESOPHAGUS
J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1289 - 1290.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. J. Reardon, A. L. Estrera, L. D. Conklin, P. R. Reardon, F. C. Brunicardi, and A. C. Beall
Esophagectomy after pneumonectomy: a surgical challenge
Ann. Thorac. Surg., January 1, 2000; 69(1): 286 - 288.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.